✦ LIBER ✦

The impact of an educational DVD on cancer patients considering participation in a phase I clinical trial

✍ Scribed by Elizabeth L. Strevel; Colin Newman; Gregory R. Pond; Martha MacLean; Lillian L. Siu

Publisher: Springer-Verlag
Year: 2006
Tongue: English
Weight: 256 KB
Volume: 15
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s00520-006-0199-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Soluble E-selectin in cancer patients as

Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial

✍ Barbara D. Wamil; Gary B. Thurman; Hakan W. Sundell; Russel F. DeVore; Gail Wake 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 703 KB

Vorinostat in advanced prostate cancer p

Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862) : Trial results and interleukin-6 analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium

✍ Deborah Bradley; Dana Rathkopf; Rodney Dunn; Walter M. Stadler; Glenn Liu; David 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

Results of the first phase 1 clinical tr

Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients : United States Military Cancer Institute Clinical Trials Group Study I-04

✍ Mark G. Carmichael; Linda C. Benavides; Jarrod P. Holmes; Jeremy D. Gates; Eliza 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views

The effect of bexarotene on atorvastatin

The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer

✍ Heather A. Wakelee; Chris H. Takimoto; Arturo Lopez-Anaya; Quincy Chu; Gary Midd 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 393 KB

Pharmacokinetics of 5,6-dimethylxantheno

Pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (AS1404), a novel vascular disrupting agent, in phase I clinical trial

✍ M. B. Jameson; B. C. Baguley; P. Kestell; L. Zhao; J. W. Paxton; P. I. Thompson; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 336 KB

A phase I, first in man study of OSI-783

A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group

✍ G. Goss; L. L. Siu; I. Gauthier; E. X. Chen; A. M. Oza; R. Goel; J. Maroun; J. P 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 233 KB